Blue Trust’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$697 Buy
+11
New +$760 ﹤0.01% 2242
2025
Q4
– Sell
-145
Closed -$6.95K – 2748
2025
Q3
$6.95K Buy
+145
New +$6.48K ﹤0.01% 1932

Other funds holding XPH

Blue Trust's XPH Position: Q3 2026 in Review

Blue Trust opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 11 shares worth $697. The stake represents ﹤0.01% of the portfolio and ranks #2242 among its holdings. This is a return to the name: Blue Trust previously reported a position in XPH as recently as Q3 2025.

Blue Trust first reported a position in XPH in Q3 2025 and has held it in 2 quarters since. The position peaked at $6.95K in Q3 2025. 100 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Blue Trust held 11 shares of State Street SPDR S&P Pharmaceuticals ETF worth $697 as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Blue Trust position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2242 holding.
  • Blue Trust first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2025 and has held it in 2 quarters since.
  • Blue Trust's State Street SPDR S&P Pharmaceuticals ETF position peaked at $6.95K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.